An overview

Drug and Alcohol Dependence

Volumn 51, Issue 1-2, 1998, Pages 215-218

  Bloom, Floyd E ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; ENDORPHIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PSYCHEDELIC AGENT;

ADAPTATION; DRUG DEPENDENCE; GENE EXPRESSION; HUMAN; HYPERACTIVITY; NEUROBIOLOGY; NEUROSCIENCE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; REVIEW; REWARD; STEREOCHEMISTRY;

EID: 0032104637     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(98)00079-9     Document Type: Article

References (55)

1. Bell, K., Kalivas, P.W., 1996. Context-specific cross-sensitization between systemic cocaine and intra-accumbens AMPA infusion in the rat. Psychopharmacology 127, 377-383.
2. Beltramo, M., Stella, N., Calignano, A., Lin, S.Y., Makriyannis, A., Piomelli, D., 1997. Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science 277, 1094-1097.
3. Blake, A.D., Bot, G., Reisine, T., 1996. Structure-function analysis of the cloned opiate receptors: peptide and small molecule interactions. Chem. Biol. 3, 967-972.
4. Bloom, F.E., 1997. The science of substance abuse. Science 278, 15.
5. Bronstein, D.M., Gutstein, H.B., Akil, H., 1993. Effects of chronic morphine treatment on beta-endorphin-related peptides in the caudal medulla and spinal cord. J. Neurochem. 60, 2304-2307.
6. Bronstein, D.M., Przewlocki, R., Akil, H., 1990. Effects of morphine treatment on pro-opiomelanocortin systems in rat brain. Brain Res. 519, 102-111.
7. 3 dopamine receptors. Science 260, 1814-1816.
8. 3 receptor test in vitro predicts decreased cocaine self-administration in rats. Neuroreport 8, 2373-2377.
9. Champion, H.C., Zadina, J.E., Kastin, A.J., Hackler, L., Ge, L.J., Kadowitz, P.J., 1997. The endogenous mu-opioid receptor agonists endomorphins 1 and 2 have novel hypotensive activity in the rabbit. Biochem. Biophys. Res. Commun. 235, 567-570.
10. Crawley, J.N., Corwin, R.L., Robinson, J.K., Felder, C.C., Devane, W.A., Axelrod, J., 1993. Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents. Pharmacol. Biochem. Behav. 46, 967-972.
11. Felder, C.C., Briley, E.M., Axelrod, J., Simpson, J.T., Mackie, K., Devane, W.A., 1993. Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction. Proc. Natl. Acad. Sci. USA 90, 7656-7660.
12. Garratt, J.C., Alreja, M., Aghajanian, G.K., 1993. LSD has high efficacy relative to serotonin in enhancing the cationic current Ih: intracellular studies in rat facial motorneurons. Synapse 13, 123-134.
13. Giros, B., Jaber, M., Jones, S.R., Wightman, R.M., Caron, M.G., 1996. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379, 606-612.
14. Goldstein, A., Archer, S., Collier, H.O.J., Herz, A., Kosterlitz, H.W., Takagi, H., Villareal, J.E., Exec. Comm., Ed. (1975). The Opiate Narcotics. Neurochemical Mechanisms in Analgesia and Dependence. New York, Pergamon Press.
15. Goldstein, A., Lowney, L.I., Pal, B.K., 1971. Stereospecific and non-specific interactions of the morphine congener levorphanol in subcellular fractions of mouse brain. Proc. Natl. Acad. Sci. USA 68, 1742-1747.
16. Hackler, L., Zadina, J.E., Ge, L.J., Kastin, A.J., 1997. Isolation of relatively large amounts of endomorphin-1 and endomorphin-2 from human brain cortex. Peptides 18, 1635-1639.
17. Heyser, C.J., McDonald, J.S., Beauchamp, V., Koob, G.F., Gold, L.H., 1997. The effects of cocaine on operant responding for food in several strains of mice. Psychopharmacology 132: 202-208.
18. 2+ channel currents in rodent NG108-15 cells overexpressing mu-opioid receptors [In Process Citation]. J. Physiol. 507, 71-75.
19. Hu, X.T., White, F.J., 1996. Glutamate receptor regulation of rat nucleus accumbens neurons in vivo. Synapse 23, 208-218.
20. Koob, G.F., 1998. Circuits, drugs, and drug addiction. Adv. Pharmacol. 42, 978-982.
21. Koob, G.F., Caine, S.B., Parsons, L., Markou, A., Weiss, F., 1997. Opponent process model and psychostimulant addiction. Pharmacol. Biochem. Behav. 57, 513-521.
22. Koob, G.F., Le Moal, M., 1997. Drug abuse: hedonic homeostatic dysregulation. Science 278, 52-58.
23. Lane-Ladd, S.B., Pineda, J., Boundy, V.A., et al., 1997. CREB (cAMP response element-binding protein) in the locus coeruleus: biochemical, physiological, and behavioral evidence for a role in opiate dependence. J. Neurosci. 17, 7890-7901.
24. Li, C., Peoples, R.W., Weight, F.F., 1994. Alcohol action on a neuronal membrane receptor: evidence for a direct interaction with the receptor protein. Proc. Natl. Acad. Sci. USA 91, 8200-8204.
25. Lowney, L.I., Schulz, K., Lowery, P.J., Goldstein, A., 1974. Partial purification of an opiate receptor from mouse brain. Science 183, 749-753.
26. Mackie, K., Devane, W.A., Hille, B., 1993. Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells. Mol. Pharmacol. 44, 498-503.
27. Mansour, A., Watson, S.J., Akil, H., 1995. Opioid receptors: past, present and future. Trends Neurosci. 18, 69-70.
28. Marek, G.J., Aghajanian, G.K., 1996. LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex. J. Pharmacol. Exp. Ther. 278, 1373-1382.
29. Masood, K., Wu, C., Brauneis, U., Weight, F.F., 1994. Differential ethanol sensitivity of recombinant N-methyl-D-aspartate receptor subunits. Mol. Pharmacol. 45, 324-329.
30. Matthes, H.W., Maldonado, R., Simonin, F., et al., 1996. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene [see comments]. Nature 383, 819-823.
31. Meunier, J.C., 1997. Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor [In Process Citation]. Eur. J. Pharmacol. 340, 1-15.
32. Missale, C., Nash, S.R., Robinson, S.W., Jaber, M., Caron, M.G., 1998. Dopamine receptors: from structure to function. Physiol. Rev. 78, 189-225.
33. Nestler, E.J., 1997. Molecular mechanisms of opiate and cocaine addiction. Curr. Opin. Neurobiol. 7, 713-719.
34. Nestler, E.J., Aghajanian, G.K., 1997. Molecular and cellular basis of addiction. Science 278, 58-63.
35. Nibuya, M., Nestler, E.J., Duman, R.S., 1996. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J. Neurosci. 16, 2365-2372.
36. Nothacker, H.P., Reinscheid, R.K., Mansour, A., et al., 1996. Primary structure and tissue distribution of the orphanin FQ precursor. Proc. Natl. Acad. Sci. USA 93, 8677-8682.
37. Olale, F., Gerzanich, V., Kuryatov, A., Wang, F., Lindstrom, J., 1997. Chronic nicotine exposure differentially affects the function of human [alpha]3, [alpha]4, and [alpha]7 neuronal nicotinic receptor subtypes. J. Pharmacol. Exp. Ther. 283, 675-683.
38. Pan, Y.X., Xu, J., Pasternak, G.W., 1996. Cloning and expression of a cDNA encoding a mouse brain orphanin FQ/nociceptin precursor. J. Biochem. 315, 11-13.
39. 3 receptor stimulation enhances cocaine reinforcement. J. Neurochem. 67, 1078-1089.
40. Peoples, R.W., Li, C., Weight, F.F., 1996. Lipid vs. protein theories of alcohol action in the nervous system. Annu. Rev. Pharmacol. Toxicol. 36, 185-201.
41. Pierce, R.C., Meil, W.M., Kalivas, P.W., 1997. The NMDA antagonist, dizocilpine, enhances cocaine reinforcement without influencing mesoaccumbens dopamine transmission. Psychopharmacology 133, 188-195.
42. Pulvirenti, L., Balducci, C., Koob, G.F., 1997. Dextromethorphan reduces intravenous cocaine self-administration in the rat. Eur. J. Pharmacol. 321, 279-283.
43. Rasmussen, K., Aghajanian, G.K., 1986. Effect of hallucinogens on spontaneous and sensory-evoked locus coeruleus unit activity in the rat: reversal by selective 5-HT2 antagonists. Brain Res. 385, 395-400.
44. Reinscheid, R.K., Higelin, J., Henningsen, R.A., Monsma, F.J., Jr., Civelli, O., 1998. Structures that delineate orphanin FQ and dynorphin A pharmacological selectivities. J. Biol. Chem. 273, 1490-1495.
45. Self, D.W., Genova, L.M., Hope, B.T., Barnhart, W.J., Spencer, J.J., Nestler, E.J., 1998. Involvement of cAMP-dependent protein kinase in the nucleus accumbens in cocaine self-administration and relapse of cocaine-seeking behavior. J. Neurosci. 18, 1848-1859.
46. Sora, I., Funada, M., Uhl, G.R., 1997. The mu-opioid receptor is necessary for [D-Pen2,D-Pen5]enkephalin-induced analgesia. Eur. J. Pharmacol. 324, R1-2.
47. 3 receptor agonists partially reproduce the discriminative stimulus effects of cocaine in squirrel monkeys. J. Pharmacol. Exp. Ther. 278, 1128-1137.
48. Stone, L.S., Fairbanks, C.A., Laughlin, T.M., et al., 1997. Spinal analgesic actions of the new endogenous opioid peptides endomorphin-1 and -2. Neuroreport 8, 3131-3135.
49. Thompson, R.C., Mansour, A., Akil, H., Watson, S.J., 1993. Cloning and pharmacological characterization of a rat mu-opioid receptor. Neuron 11, 903-913.
50. Trujillo, K.A., Akil, H., 1994. Inhibition of opiate tolerance by non-competitive N-methyl-D-aspartate receptor antagonists. Brain Res. 633, 178-188.
51. Ueda, H., Yamaguchi, T., Tokuyama, S., Inoue, M., Nishi, M., Takeshima, H., 1997. Partial loss of tolerance liability to morphine analgesia in mice lacking the nociceptin receptor gene. Neurosci. Lett. 237, 136-138.
52. Weiss, F., Parsons, L.H., Schulteis, G., et al., 1996. Ethanol self-administration restores withdrawal-associated deficiencies in accumbal dopamine and 5-hydroxytryptamine release in dependent rats. J. Neurosci. 16, 3474-3485.
53. Widnell, K.L., Chen, J.S., Iredale, P.A., et al., 1996. Transcriptional regulation of CREB (cyclic AMP response element-binding protein) expression in CATH.a cells. J. Neurochem. 66, 1770-1773.
54. Winter, B.A., Goldstein, A., 1972. A photochemical affinity-labelling reagent for the opiate receptor(s). Mol. Pharmacol. 8, 601-611.
55. Zhang, X.F., Hu, X.T., White, F.J., Wolf, M.E., 1997. Increased responsiveness of ventral tegmental area dopamine neurons to glutamate after repeated administration of cocaine or amphetamine is transient and selectively involves AMPA receptors. J. Pharmacol. Exp. Ther. 281, 699-706.